ACHIEVE Trademark

Trademark Overview


On Friday, September 27, 2024, a trademark application was filed for ACHIEVE with the United States Patent and Trademark Office. The USPTO has given the ACHIEVE trademark a serial number of 98774474. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, April 7, 2025. This trademark is owned by Achieve Life Sciences, Inc.. The ACHIEVE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing information regarding health diagnosis, medical conditions and treatment to patients and healthcare providers
achieve

General Information


Serial Number98774474
Word MarkACHIEVE
Filing DateFriday, September 27, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, April 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding information regarding health diagnosis, medical conditions and treatment to patients and healthcare providers

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 27, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAchieve Life Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBothell, WA 98021

Trademark Events


Event DateEvent Description
Friday, September 27, 2024NEW APPLICATION ENTERED
Wednesday, April 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 3, 2025ASSIGNED TO EXAMINER
Monday, April 7, 2025NON-FINAL ACTION WRITTEN
Monday, April 7, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 7, 2025NON-FINAL ACTION E-MAILED